Showing results (1341-1350 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|April 9, 2015
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-TRachel A Burga, Mitchell Thorn, Gary R Point, et al.Cancer Immunology, Immunotherapy : CII|July 11, 2020
Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitorsEiki Ichihara, Daijiro Harada, Koji Inoue, et al.Cancer Immunology, Immunotherapy : CII|July 13, 2020
ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancerJiexia Zhang, Ningning Zhou, Anqi Lin, et al.Cancer Immunology, Immunotherapy : CII|July 15, 2020
NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomasJohn W Rutland, Corey M Gill, Joshua Loewenstern, et al.Cancer Immunology, Immunotherapy : CII|July 12, 2020
Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responsesNiklas Remke, Savita Bisht, Sebastian Oberbeck, et al.Cancer Immunology, Immunotherapy : CII|August 2, 2020
Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1Anna Makowska, Selina Meier, Lian Shen, et al.Cancer Immunology, Immunotherapy : CII|January 24, 2014
Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunityZoya Alteber, Meir Azulay, Gal Cafri, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1987
T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivoC M Henningsson, S Selvaraj, G D MacLean, et al.Cancer Immunology, Immunotherapy : CII|November 10, 2012
Immunomodulatory activity of SGI-110, a 5-aza-2'-deoxycytidine-containing demethylating dinucleotideSandra Coral, Giulia Parisi, Hugues J M G Nicolay, et al.Cancer Immunology, Immunotherapy : CII|November 13, 2012
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapyDaisuke Nobuoka, Toshiaki Yoshikawa, Mari Takahashi, et al.Pageof 651